Anita Vasudevan

Anita Vasudevan is special counsel at Cooley LLP in Palo Alto. According to the firm, she works with a broad base of clients, including software, Internet of Things, edtech, cleantech, and medical device companies, and routinely represents venture capital and corporate investors in financing transactions.

The firm states that she has substantial experience in a variety of corporate transactions, including venture capital financings, mergers and acquisitions, and public offerings. Her practice also includes general business advising with respect to corporate securities, commercial agreements, and corporate governance matters. Matters listed on her firm bio include advising Inflammatix on its $102 million Series D financing, Iconic Therapeutics on its $40 million Series C financing, IDEV Technologies in its $310 million acquisition by Abbott Laboratories, Triphase Accelerator Corporation in its partnership and option-to-acquire arrangement with Celgene, and BrightFarms on its $100 million Series E financing.

Vasudevan is admitted to practice in California, with State Bar admission listed in 1997 and an active license. Her listed related services at the firm include emerging companies, venture capital, and mergers and acquisitions.